Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
gonzalo.rodriguez@oncology.ox.ac.uk

Gonzalo Rodriguez Berriguete

Recent publications

Structure-guided optimisation of fenofibrate-derived oxidative phosphorylation inhibitors to modify tumour hypoxia.

Holt-Martyn JP. et al, (2026), RSC Med Chem

UPR-induced intracellular C5aR1 promotes adaptation to the hypoxic tumour microenvironment.

Suwa T. et al, (2025), Cell Death Dis, 16

UPR-induced intracellular C5aR1 promotes adaptation to the hypoxic tumour microenvironment by regulating tumour cell fate

Suwa T. et al, (2024)

Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models.

Rodriguez-Berriguete G. et al, (2024), Cell Death Dis, 15

Repurposing radiosensitising medicines for radiotherapy: an overview.

Low JM. et al, (2024), BMJ Oncol, 3